Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

Learn more about whether Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Merus leads biotech with its innovative antibody platforms, strong financials, and promising petosemtamab targeting cancer.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The American ...

Learn more about whether Jazz Pharmaceuticals plc or Merck & Co., Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

The Rybrevant-Lazcluze combo significantly reduced the risk of ... president of oncology global medical affairs for J&J Innovative Medicine, said in an interview with Fierce Pharma.

That would allow Nubeqa to try to claim market share ... said Bayer's pharma chief Stefan Oelrich. That includes a second phase 3 trial in metastatic hormone-sensitive prostate cancer, ARANOTE ...

Oncology is orphaned One way that pharmaceutical companies have mitigated these risks is to pursue orphan indications for products' initial launches. The Orphan Drug Act of 1983 grants special ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr Pharma, Inc. (NASDAQ:ATYR) stands against other hot biotech stocks under $5.

Pharma firm GSK has been accused of burying a report said ... was that there was ‘no consistent or reliable evidence that ranitidine increases the risk of… cancer‘. In October, GSK said it had spent ...

Bayer said in its petition that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the U.S. Environmental ... CEO Bill Anderson has ...